Bill journey · stage 2 of 5
Under committee review
What it doesSummary reported to senate (Jun 28, 2019)
Prescription Pricing for the People Act of 2019
This bill requires the Federal Trade Commission (FTC) to report about anticompetitive practices and other trends within the pharmaceutical supply chain that may impact the cost of prescriptions drugs. The FTC also must provide recommendations to increase transparency in the supply chain and prevent anticompetitive practices.
What just happenedJun 28, 2019
Placed on Senate Legislative Calendar under General Orders. Calendar No. 131.
Who’s behind it
Placed on Senate Legislative Calendar under General Orders. Calendar No. 131.
Committee on the Judiciary. Reported by Senator Graham with an amendment in the nature of a substitute. Without written report.
Committee on the Judiciary. Reported by Senator Graham with an amendment in the nature of a substitute. Without written report.
Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
Read twice and referred to the Committee on the Judiciary.
Introduced in Senate
Prescription Pricing for the People Act of 2019
This bill requires the Federal Trade Commission (FTC) to report about anticompetitive practices and other trends within the pharmaceutical supply chain that may impact the cost of prescriptions drugs. The FTC also must provide recommendations to increase transparency in the supply chain and prevent anticompetitive practices.
Prescription Pricing for the People Act of 2019
This bill directs the Federal Trade Commission to report to Congress on the effect of certain anticompetitive practices in the pharmaceutical supply chain.